Acetaminophen/paracetamol ( DrugBank: Acetaminophen, Paracetamol )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
35	天疱瘡	1
49	全身性エリテマトーデス	1

35. 天疱瘡

臨床試験数 : 98 / 薬物数 : 126 - (DrugBank : 41) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 168

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02613910 (ClinicalTrials.gov)	December 23, 2015	23/11/2015	Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris	OPV117059: A Long-Term Extension Study of Ofatumumab Injection for Subcutaneous Use in Subjects With ...	Pemphigus	Drug: Ofatumumab;Drug: Acetaminophen/paracetamol;Drug: Antihistamine (cetirizine or equivalent);Drug ...	GlaxoSmithKline	NULL	Terminated	N/A	N/A	All	1	Phase 3	United States

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04963296 (ClinicalTrials.gov)	October 26, 2021	7/7/2021	A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Eryt ...	A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficac ...	Systemic Lupus Erythematosus	Drug: Obinutuzumab;Drug: Placebo;Drug: Acetaminophen/Paracetamol;Drug: Diphenhydramine hydrochloride ...	Hoffmann-La Roche	NULL	Recruiting	18 Years	75 Years	All	200	Phase 3	United States;Argentina;France;Italy;Mexico;New Zealand;Peru;Russian Federation;South Africa;Spain;B ...